查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1862177

临床试验用品供应：全球市场份额和排名、总收入和需求预测（2025-2031 年）

Clinical Trial Supplies - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年全球临床试验用品市场规模估计为 23.64 亿美元，预计到 2031 年将达到 40.99 亿美元，在预测期（2025-2031 年）内复合年增长率为 8.3%。

临床试验供应是指为製药公司、生技公司和受託研究机构(CRO) 在整个临床试验生命週期中提供临床实验药物、对照药物、试剂、医疗设备和辅助材料的综合供应系统。核心服务包括临床实验药物的生产、重新包装、贴标、批次追踪和储存，以及临床检体采集试剂盒、伴随诊断试剂和检测专用设备的采购和交付。随着创新药物数量的不断增加、多中心国际临床试验的日益复杂化以及个人化医疗的进步，临床试验供应已成为药物研发的关键要素。透过整合数位化供应链管理、低温运输物流和合规运营，我们提供端到端、高品质、可追溯的供应解决方案，加速药物的临床检验和商业化进程，体现了我们在生命科学产业的创新能力和全球竞争力。

临床试验供应产业的成长动力源自于全球创新药物和先进治疗方法研发管线的快速扩张，以及多中心、国际性试验日益复杂的趋势。细胞和基因疗法、RNA药物以及精准医疗的日益普及，催生了对高度客製化、灵活且符合监管要求的供应解决方案的强劲需求。製药公司正加大对策略伙伴关係和数位化供应链专案的投入，以提高试验效率和监管合规性。同时，政府对医药创新的支持以及不断完善的法规结构也推动了产业发展，使临床试验供应成为生命科学创新的基石。

由于复杂的全球监管要求和不断上涨的营运成本，该行业面临许多挑战。各国在药品生产品质管理规范/药品生产品质管理规范 (GMP/GDP) 标准、药品分销政策和海关程序方面的差异，使跨境供应链更加复杂。对低温运输运输、批次追溯和合规性审核日益增长的需求，要求持续投资于基础设施、技术和人力资源开发。市场竞争、供应链中断、地缘政治紧张局势和公共卫生危机进一步加剧了全球业务营运的风险。

随着临床试验模式从集中式转向分散式、数位化和以患者为中心的模式转变，对试验耗材的需求也变得更加多样化和复杂。製药公司和合约研究组织（CRO）需要提高供应链的透明度、风险管理能力和资源分配的精准性。伴随诊断、基因组检测和罕见疾病研究的兴起，推动了对高度客製化小批量耗材解决方案的需求。此外，远端医疗和直接面向患者（DTP）的试验模式正在扩大服务的覆盖范围和灵活性，并为临床试验物流的创新创造了机会。

上游环节包括临床实验原料药、品管、试验试剂、专用包装及低温运输运输系统。製药企业、原料供应商和医疗设备製造商的技术创新正在推动供应链服务品质的整体提升。智慧包装解决方案、高性能保温设备和先进的温度监控设备正日益成为标准配备。此外，数位化供应链平台和自动化仓储系统的应用正在提高营运效率和标准化程度，增强临床试验用品的全球分销能力。

本报告旨在按地区/国家、类型和应用对全球临床试验用品市场进行全面分析，重点关注总收入、市场份额和主要企业的排名。

本报告以销售收入为指标，对临床试验用品市场规模、估算和预测进行了呈现，基准年为2024年，并涵盖了2020年至2031年的历史数据和预测数据。透过定量和定性分析，我们帮助读者制定业务/成长策略，评估市场竞争格局，分析自身在当前市场中的地位，并就临床试验用品做出明智的商业决策。

市场区隔

公司

  • Thermo Fisher Scientific
  • Catalent Pharma Solutions
  • Almac Group
  • Parexel International
  • UDG Healthcare
  • PCI Services
  • Marken
  • Klifo A/S.
  • Walden Group
  • Bilcare Limited
  • Biocair

按类型分類的细分市场

  • 物流/配送
  • 生产/包装
  • 供应链管理
  • 其他的

应用领域

  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 其他的

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Clinical Trial Supplies was estimated to be worth US$ 2364 million in 2024 and is forecast to a readjusted size of US$ 4099 million by 2031 with a CAGR of 8.3% during the forecast period 2025-2031.

Clinical Trial Supplies refer to the comprehensive supply system of investigational products, comparators, reagents, medical equipment, and ancillary materials required throughout the entire lifecycle of clinical trials for pharmaceutical companies, biotechnology firms, and contract research organizations (CROs). Core services include the manufacturing, repackaging, labeling, batch tracking, and storage of investigational drugs, as well as the sourcing and delivery of clinical sample collection kits, companion diagnostics, and trial-specific devices. As the number of innovative drugs grows, multi-center international clinical trials become more complex, and personalized medicine advances, clinical trial supplies have become an indispensable component of pharmaceutical R&D. By integrating digital supply chain management, cold-chain logistics, and compliance-driven operations, the sector provides end-to-end, high-quality, traceable supply solutions that accelerate clinical validation and commercialization of drugs, reflecting both innovation capacity and global competitiveness in the life sciences industry.

The clinical trial supplies industry is driven by the rapid growth of global pipelines for innovative drugs and advanced therapies, as well as the rising complexity of multi-center international trials. The expanding adoption of cell and gene therapies, RNA-based drugs, and precision medicine has created a strong demand for highly customized, flexible, and compliance-oriented supply solutions. Pharmaceutical companies are increasingly investing in strategic partnerships and digital supply chain initiatives to enhance trial efficiency and regulatory adherence. In parallel, government support for drug innovation and evolving regulatory frameworks are fostering industry growth, positioning clinical trial supplies as a cornerstone of life sciences innovation.

The sector faces challenges stemming from complex global regulatory requirements and rising operational costs. Differences in GMP/GDP standards, drug distribution policies, and customs clearance procedures across countries complicate cross-border supply chains. The growing need for cold-chain transportation, batch traceability, and compliance audits necessitates ongoing investment in infrastructure, technology, and workforce training. Market competition, supply chain disruptions, geopolitical tensions, and public health crises further increase risks for global operations.

As clinical trials shift from centralized to decentralized, digital, and patient-centric models, demand for trial supplies is becoming more diversified and sophisticated. Pharmaceutical companies and CROs require greater supply chain visibility, risk management, and precise resource allocation. The rise of companion diagnostics, genomic testing, and rare disease research has fueled the demand for highly customized, small-batch supply solutions. Additionally, telemedicine and direct-to-patient (DTP) trial models are expanding service reach and flexibility, unlocking new opportunities for innovation in clinical trial logistics.

The upstream segment comprises investigational drug substances, comparator products, laboratory reagents, specialized packaging, and cold-chain transportation systems. Technological advancements by pharmaceutical manufacturers, raw material suppliers, and medical device firms have enhanced the overall quality of supply services. Smart packaging solutions, high-performance insulation equipment, and advanced temperature monitoring devices are increasingly standard. Furthermore, the adoption of digital supply chain platforms and automated warehousing is improving operational efficiency and standardization, strengthening global distribution capabilities for clinical trial supplies.

This report aims to provide a comprehensive presentation of the global market for Clinical Trial Supplies, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Clinical Trial Supplies by region & country, by Type, and by Application.

The Clinical Trial Supplies market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Trial Supplies.

Market Segmentation

By Company

  • Thermo Fisher Scientific
  • Catalent Pharma Solutions
  • Almac Group
  • Parexel International
  • UDG Healthcare
  • PCI Services
  • Marken
  • Klifo A/S.
  • Walden Group
  • Bilcare Limited
  • Biocair

Segment by Type

  • Logistics & Distribution
  • Manufacturing and Packaging
  • Supply Chain Management
  • Other

Segment by Application

  • Phase I
  • Phase II
  • Phase III
  • Other

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Clinical Trial Supplies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Clinical Trial Supplies in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Clinical Trial Supplies in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Clinical Trial Supplies Product Introduction
  • 1.2 Global Clinical Trial Supplies Market Size Forecast (2020-2031)
  • 1.3 Clinical Trial Supplies Market Trends & Drivers
    • 1.3.1 Clinical Trial Supplies Industry Trends
    • 1.3.2 Clinical Trial Supplies Market Drivers & Opportunity
    • 1.3.3 Clinical Trial Supplies Market Challenges
    • 1.3.4 Clinical Trial Supplies Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Clinical Trial Supplies Players Revenue Ranking (2024)
  • 2.2 Global Clinical Trial Supplies Revenue by Company (2020-2025)
  • 2.3 Key Companies Clinical Trial Supplies Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Clinical Trial Supplies Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Clinical Trial Supplies
  • 2.6 Clinical Trial Supplies Market Competitive Analysis
    • 2.6.1 Clinical Trial Supplies Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Clinical Trial Supplies Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trial Supplies as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Logistics & Distribution
    • 3.1.2 Manufacturing and Packaging
    • 3.1.3 Supply Chain Management
    • 3.1.4 Other
  • 3.2 Global Clinical Trial Supplies Sales Value by Type
    • 3.2.1 Global Clinical Trial Supplies Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Clinical Trial Supplies Sales Value, by Type (2020-2031)
    • 3.2.3 Global Clinical Trial Supplies Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Phase I
    • 4.1.2 Phase II
    • 4.1.3 Phase III
    • 4.1.4 Other
  • 4.2 Global Clinical Trial Supplies Sales Value by Application
    • 4.2.1 Global Clinical Trial Supplies Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Clinical Trial Supplies Sales Value, by Application (2020-2031)
    • 4.2.3 Global Clinical Trial Supplies Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Clinical Trial Supplies Sales Value by Region
    • 5.1.1 Global Clinical Trial Supplies Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Clinical Trial Supplies Sales Value by Region (2020-2025)
    • 5.1.3 Global Clinical Trial Supplies Sales Value by Region (2026-2031)
    • 5.1.4 Global Clinical Trial Supplies Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Clinical Trial Supplies Sales Value, 2020-2031
    • 5.2.2 North America Clinical Trial Supplies Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Clinical Trial Supplies Sales Value, 2020-2031
    • 5.3.2 Europe Clinical Trial Supplies Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Clinical Trial Supplies Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Clinical Trial Supplies Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Clinical Trial Supplies Sales Value, 2020-2031
    • 5.5.2 South America Clinical Trial Supplies Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Clinical Trial Supplies Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Clinical Trial Supplies Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Clinical Trial Supplies Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Clinical Trial Supplies Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Clinical Trial Supplies Sales Value, 2020-2031
    • 6.3.2 United States Clinical Trial Supplies Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Clinical Trial Supplies Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Clinical Trial Supplies Sales Value, 2020-2031
    • 6.4.2 Europe Clinical Trial Supplies Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Clinical Trial Supplies Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Clinical Trial Supplies Sales Value, 2020-2031
    • 6.5.2 China Clinical Trial Supplies Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Clinical Trial Supplies Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Clinical Trial Supplies Sales Value, 2020-2031
    • 6.6.2 Japan Clinical Trial Supplies Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Clinical Trial Supplies Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Clinical Trial Supplies Sales Value, 2020-2031
    • 6.7.2 South Korea Clinical Trial Supplies Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Clinical Trial Supplies Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Clinical Trial Supplies Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Clinical Trial Supplies Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Clinical Trial Supplies Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Clinical Trial Supplies Sales Value, 2020-2031
    • 6.9.2 India Clinical Trial Supplies Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Clinical Trial Supplies Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Thermo Fisher Scientific
    • 7.1.1 Thermo Fisher Scientific Profile
    • 7.1.2 Thermo Fisher Scientific Main Business
    • 7.1.3 Thermo Fisher Scientific Clinical Trial Supplies Products, Services and Solutions
    • 7.1.4 Thermo Fisher Scientific Clinical Trial Supplies Revenue (US$ Million) & (2020-2025)
    • 7.1.5 Thermo Fisher Scientific Recent Developments
  • 7.2 Catalent Pharma Solutions
    • 7.2.1 Catalent Pharma Solutions Profile
    • 7.2.2 Catalent Pharma Solutions Main Business
    • 7.2.3 Catalent Pharma Solutions Clinical Trial Supplies Products, Services and Solutions
    • 7.2.4 Catalent Pharma Solutions Clinical Trial Supplies Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Catalent Pharma Solutions Recent Developments
  • 7.3 Almac Group
    • 7.3.1 Almac Group Profile
    • 7.3.2 Almac Group Main Business
    • 7.3.3 Almac Group Clinical Trial Supplies Products, Services and Solutions
    • 7.3.4 Almac Group Clinical Trial Supplies Revenue (US$ Million) & (2020-2025)
    • 7.3.5 Almac Group Recent Developments
  • 7.4 Parexel International
    • 7.4.1 Parexel International Profile
    • 7.4.2 Parexel International Main Business
    • 7.4.3 Parexel International Clinical Trial Supplies Products, Services and Solutions
    • 7.4.4 Parexel International Clinical Trial Supplies Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Parexel International Recent Developments
  • 7.5 UDG Healthcare
    • 7.5.1 UDG Healthcare Profile
    • 7.5.2 UDG Healthcare Main Business
    • 7.5.3 UDG Healthcare Clinical Trial Supplies Products, Services and Solutions
    • 7.5.4 UDG Healthcare Clinical Trial Supplies Revenue (US$ Million) & (2020-2025)
    • 7.5.5 UDG Healthcare Recent Developments
  • 7.6 PCI Services
    • 7.6.1 PCI Services Profile
    • 7.6.2 PCI Services Main Business
    • 7.6.3 PCI Services Clinical Trial Supplies Products, Services and Solutions
    • 7.6.4 PCI Services Clinical Trial Supplies Revenue (US$ Million) & (2020-2025)
    • 7.6.5 PCI Services Recent Developments
  • 7.7 Marken
    • 7.7.1 Marken Profile
    • 7.7.2 Marken Main Business
    • 7.7.3 Marken Clinical Trial Supplies Products, Services and Solutions
    • 7.7.4 Marken Clinical Trial Supplies Revenue (US$ Million) & (2020-2025)
    • 7.7.5 Marken Recent Developments
  • 7.8 Klifo A/S.
    • 7.8.1 Klifo A/S. Profile
    • 7.8.2 Klifo A/S. Main Business
    • 7.8.3 Klifo A/S. Clinical Trial Supplies Products, Services and Solutions
    • 7.8.4 Klifo A/S. Clinical Trial Supplies Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Klifo A/S. Recent Developments
  • 7.9 Walden Group
    • 7.9.1 Walden Group Profile
    • 7.9.2 Walden Group Main Business
    • 7.9.3 Walden Group Clinical Trial Supplies Products, Services and Solutions
    • 7.9.4 Walden Group Clinical Trial Supplies Revenue (US$ Million) & (2020-2025)
    • 7.9.5 Walden Group Recent Developments
  • 7.10 Bilcare Limited
    • 7.10.1 Bilcare Limited Profile
    • 7.10.2 Bilcare Limited Main Business
    • 7.10.3 Bilcare Limited Clinical Trial Supplies Products, Services and Solutions
    • 7.10.4 Bilcare Limited Clinical Trial Supplies Revenue (US$ Million) & (2020-2025)
    • 7.10.5 Bilcare Limited Recent Developments
  • 7.11 Biocair
    • 7.11.1 Biocair Profile
    • 7.11.2 Biocair Main Business
    • 7.11.3 Biocair Clinical Trial Supplies Products, Services and Solutions
    • 7.11.4 Biocair Clinical Trial Supplies Revenue (US$ Million) & (2020-2025)
    • 7.11.5 Biocair Recent Developments

8 Industry Chain Analysis

  • 8.1 Clinical Trial Supplies Industrial Chain
  • 8.2 Clinical Trial Supplies Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Clinical Trial Supplies Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Clinical Trial Supplies Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Clinical Trial Supplies Market Trends
  • Table 2. Clinical Trial Supplies Market Drivers & Opportunity
  • Table 3. Clinical Trial Supplies Market Challenges
  • Table 4. Clinical Trial Supplies Market Restraints
  • Table 5. Global Clinical Trial Supplies Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Clinical Trial Supplies Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Clinical Trial Supplies Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Clinical Trial Supplies Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Clinical Trial Supplies
  • Table 10. Global Clinical Trial Supplies Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trial Supplies as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Clinical Trial Supplies Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Clinical Trial Supplies Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Clinical Trial Supplies Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Clinical Trial Supplies Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Clinical Trial Supplies Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Clinical Trial Supplies Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Clinical Trial Supplies Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global Clinical Trial Supplies Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global Clinical Trial Supplies Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global Clinical Trial Supplies Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global Clinical Trial Supplies Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Clinical Trial Supplies Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Clinical Trial Supplies Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Clinical Trial Supplies Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Clinical Trial Supplies Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Clinical Trial Supplies Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Clinical Trial Supplies Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Clinical Trial Supplies Sales Value, (2026-2031) & (US$ Million)
  • Table 31. Thermo Fisher Scientific Basic Information List
  • Table 32. Thermo Fisher Scientific Description and Business Overview
  • Table 33. Thermo Fisher Scientific Clinical Trial Supplies Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Clinical Trial Supplies Business of Thermo Fisher Scientific (2020-2025)
  • Table 35. Thermo Fisher Scientific Recent Developments
  • Table 36. Catalent Pharma Solutions Basic Information List
  • Table 37. Catalent Pharma Solutions Description and Business Overview
  • Table 38. Catalent Pharma Solutions Clinical Trial Supplies Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Clinical Trial Supplies Business of Catalent Pharma Solutions (2020-2025)
  • Table 40. Catalent Pharma Solutions Recent Developments
  • Table 41. Almac Group Basic Information List
  • Table 42. Almac Group Description and Business Overview
  • Table 43. Almac Group Clinical Trial Supplies Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Clinical Trial Supplies Business of Almac Group (2020-2025)
  • Table 45. Almac Group Recent Developments
  • Table 46. Parexel International Basic Information List
  • Table 47. Parexel International Description and Business Overview
  • Table 48. Parexel International Clinical Trial Supplies Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Clinical Trial Supplies Business of Parexel International (2020-2025)
  • Table 50. Parexel International Recent Developments
  • Table 51. UDG Healthcare Basic Information List
  • Table 52. UDG Healthcare Description and Business Overview
  • Table 53. UDG Healthcare Clinical Trial Supplies Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Clinical Trial Supplies Business of UDG Healthcare (2020-2025)
  • Table 55. UDG Healthcare Recent Developments
  • Table 56. PCI Services Basic Information List
  • Table 57. PCI Services Description and Business Overview
  • Table 58. PCI Services Clinical Trial Supplies Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Clinical Trial Supplies Business of PCI Services (2020-2025)
  • Table 60. PCI Services Recent Developments
  • Table 61. Marken Basic Information List
  • Table 62. Marken Description and Business Overview
  • Table 63. Marken Clinical Trial Supplies Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Clinical Trial Supplies Business of Marken (2020-2025)
  • Table 65. Marken Recent Developments
  • Table 66. Klifo A/S. Basic Information List
  • Table 67. Klifo A/S. Description and Business Overview
  • Table 68. Klifo A/S. Clinical Trial Supplies Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Clinical Trial Supplies Business of Klifo A/S. (2020-2025)
  • Table 70. Klifo A/S. Recent Developments
  • Table 71. Walden Group Basic Information List
  • Table 72. Walden Group Description and Business Overview
  • Table 73. Walden Group Clinical Trial Supplies Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Clinical Trial Supplies Business of Walden Group (2020-2025)
  • Table 75. Walden Group Recent Developments
  • Table 76. Bilcare Limited Basic Information List
  • Table 77. Bilcare Limited Description and Business Overview
  • Table 78. Bilcare Limited Clinical Trial Supplies Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in Clinical Trial Supplies Business of Bilcare Limited (2020-2025)
  • Table 80. Bilcare Limited Recent Developments
  • Table 81. Biocair Basic Information List
  • Table 82. Biocair Description and Business Overview
  • Table 83. Biocair Clinical Trial Supplies Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in Clinical Trial Supplies Business of Biocair (2020-2025)
  • Table 85. Biocair Recent Developments
  • Table 86. Key Raw Materials Lists
  • Table 87. Raw Materials Key Suppliers Lists
  • Table 88. Clinical Trial Supplies Downstream Customers
  • Table 89. Clinical Trial Supplies Distributors List
  • Table 90. Research Programs/Design for This Report
  • Table 91. Key Data Information from Secondary Sources
  • Table 92. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Clinical Trial Supplies Product Picture
  • Figure 2. Global Clinical Trial Supplies Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Clinical Trial Supplies Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Clinical Trial Supplies Report Years Considered
  • Figure 5. Global Clinical Trial Supplies Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Clinical Trial Supplies Revenue in 2024
  • Figure 7. Clinical Trial Supplies Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Logistics & Distribution Picture
  • Figure 9. Manufacturing and Packaging Picture
  • Figure 10. Supply Chain Management Picture
  • Figure 11. Other Picture
  • Figure 12. Global Clinical Trial Supplies Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 13. Global Clinical Trial Supplies Sales Value Market Share by Type, 2024 & 2031
  • Figure 14. Product Picture of Phase I
  • Figure 15. Product Picture of Phase II
  • Figure 16. Product Picture of Phase III
  • Figure 17. Product Picture of Other
  • Figure 18. Global Clinical Trial Supplies Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 19. Global Clinical Trial Supplies Sales Value Market Share by Application, 2024 & 2031
  • Figure 20. North America Clinical Trial Supplies Sales Value (2020-2031) & (US$ Million)
  • Figure 21. North America Clinical Trial Supplies Sales Value by Country (%), 2024 VS 2031
  • Figure 22. Europe Clinical Trial Supplies Sales Value, (2020-2031) & (US$ Million)
  • Figure 23. Europe Clinical Trial Supplies Sales Value by Country (%), 2024 VS 2031
  • Figure 24. Asia Pacific Clinical Trial Supplies Sales Value, (2020-2031) & (US$ Million)
  • Figure 25. Asia Pacific Clinical Trial Supplies Sales Value by Region (%), 2024 VS 2031
  • Figure 26. South America Clinical Trial Supplies Sales Value, (2020-2031) & (US$ Million)
  • Figure 27. South America Clinical Trial Supplies Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Middle East & Africa Clinical Trial Supplies Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Middle East & Africa Clinical Trial Supplies Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Key Countries/Regions Clinical Trial Supplies Sales Value (%), (2020-2031)
  • Figure 31. United States Clinical Trial Supplies Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. United States Clinical Trial Supplies Sales Value by Type (%), 2024 VS 2031
  • Figure 33. United States Clinical Trial Supplies Sales Value by Application (%), 2024 VS 2031
  • Figure 34. Europe Clinical Trial Supplies Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Europe Clinical Trial Supplies Sales Value by Type (%), 2024 VS 2031
  • Figure 36. Europe Clinical Trial Supplies Sales Value by Application (%), 2024 VS 2031
  • Figure 37. China Clinical Trial Supplies Sales Value, (2020-2031) & (US$ Million)
  • Figure 38. China Clinical Trial Supplies Sales Value by Type (%), 2024 VS 2031
  • Figure 39. China Clinical Trial Supplies Sales Value by Application (%), 2024 VS 2031
  • Figure 40. Japan Clinical Trial Supplies Sales Value, (2020-2031) & (US$ Million)
  • Figure 41. Japan Clinical Trial Supplies Sales Value by Type (%), 2024 VS 2031
  • Figure 42. Japan Clinical Trial Supplies Sales Value by Application (%), 2024 VS 2031
  • Figure 43. South Korea Clinical Trial Supplies Sales Value, (2020-2031) & (US$ Million)
  • Figure 44. South Korea Clinical Trial Supplies Sales Value by Type (%), 2024 VS 2031
  • Figure 45. South Korea Clinical Trial Supplies Sales Value by Application (%), 2024 VS 2031
  • Figure 46. Southeast Asia Clinical Trial Supplies Sales Value, (2020-2031) & (US$ Million)
  • Figure 47. Southeast Asia Clinical Trial Supplies Sales Value by Type (%), 2024 VS 2031
  • Figure 48. Southeast Asia Clinical Trial Supplies Sales Value by Application (%), 2024 VS 2031
  • Figure 49. India Clinical Trial Supplies Sales Value, (2020-2031) & (US$ Million)
  • Figure 50. India Clinical Trial Supplies Sales Value by Type (%), 2024 VS 2031
  • Figure 51. India Clinical Trial Supplies Sales Value by Application (%), 2024 VS 2031
  • Figure 52. Clinical Trial Supplies Industrial Chain
  • Figure 53. Clinical Trial Supplies Manufacturing Cost Structure
  • Figure 54. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 55. Bottom-up and Top-down Approaches for This Report
  • Figure 56. Data Triangulation
  • Figure 57. Key Executives Interviewed